Mettler-Toledo International Inc. — Q1 2019 Form 10-Q
Business context and reporting period. Unaudited results cover the three months ended March 31, 2019, compared with the same period in 2018. The company supplies precision instruments and related services across laboratory, industrial, and food-retailing markets.
Key financial metrics
| Metric | Q1 2019 | Q1 2018 | Change |
|---|---|---|---|
| Net sales | $679.5 million | $660.8 million | +3% reported; +7% in local currencies |
| Gross profit / margin | $388.3 million / 57.2% | $374.9 million / 56.7% | Margin +0.5 percentage points |
| Earnings before taxes | $125.7 million | $117.4 million | +7% |
| Net earnings | $111.8 million | $93.3 million | +20% |
| Diluted EPS | $4.42 | $3.58 | +23% |
| Operating cash flow | $98.8 million | $76.6 million | +$22.2 million |
| Capital expenditures | $22.4 million | $29.8 million | Down $7.4 million |
Net margin was 16.5%, versus 14.1% a year earlier. The reported tax rate was 11%, compared with 21%; management attributed the difference from the projected annual effective rate principally to the timing of excess tax benefits from stock-option exercises.
At March 31, cash and cash equivalents were $126.5 million, current assets $969.4 million, and current liabilities $708.0 million. Total debt was $1.062 billion, including $53.8 million current and $1.008 billion long-term; available capacity under the credit agreement was approximately $575.2 million. Cash declined $51.6 million during the quarter. The company repurchased $186.3 million of shares and paid $10 million of Biotix contingent consideration.
Material changes and operating performance
- Product sales increased 3% in U.S. dollars and 7% in local currency; service revenue increased 3% and 8%, respectively.
- Laboratory sales grew 4% reported and 8% in local currency; industrial sales grew 3% and 8%. Food-retailing sales fell 9% reported and 5% in local currency, mainly reflecting weaker Americas sales tied to project timing.
- Segment profit rose to $147.8 million from $139.5 million. Western European and Swiss segment profit increased substantially; Chinese segment profit was approximately flat and Other segment profit declined.
- Gross margin improved, reflecting favorable pricing and productivity, partly offset by tariff costs and initial costs for new product introductions. SG&A and R&D increased in local currency, reflecting investment in sales, service, growth initiatives, and R&D activity.
Outlook, risks, and unusual items
- No specific full-year sales or earnings guidance is provided in the supplied filing text. Management said global market conditions were generally favorable but noted economic uncertainty, particularly in some regions and emerging markets, and cautioned that Q1 results are not necessarily indicative of full-year results.
- The company estimated an annualized cost increase of approximately $25 million from U.S. tariffs on certain China-origin imports, assuming a 25% tariff rate, and said it was evaluating mitigation actions.
- Currency exposure is significant: management estimated that a 1% Swiss franc strengthening against the euro could reduce annual pretax earnings by $1.6–$1.8 million; a 1% weakening of the Chinese renminbi against the U.S. dollar could reduce annual pretax earnings by $1.5–$1.7 million. A 10% weakening of the U.S. dollar against debt currencies would increase reported debt by about $30.2 million.
- In April 2019, the company agreed to issue $75 million of 10-year notes at a fixed 3.91% rate, expected to close in June. It also expected $10–$15 million of net investment in new or expanded manufacturing facilities over the next two years.
- ASC 842 lease accounting was adopted January 1, 2019; at March 31, operating lease liabilities were $86.8 million. Management reported no material adverse effect expected from ongoing legal proceedings. The quarter included $1.5 million of restructuring charges.
Important facts for investors to verify
- Whether local-currency sales momentum continues and food-retailing weakness remains a timing issue or becomes more persistent.
- How tariff mitigation affects costs and margins relative to the estimated $25 million annualized exposure.
- Debt, cash generation, and share-repurchase pace, including the effect of the additional $75 million note issuance.
- Whether the unusually low reported tax rate recurs; management’s projected annual effective tax rate before discrete items was 20.5%.
- Developments in currency exposure, regional economic conditions, and planned capital investment.